世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

医療向け人工知能(AI)市場 - 世界の機会分析と産業予測 2018-2025年

Artificial Intelligence in Medicine Market by Product Type (Hardware, Software, and Services), Technology (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), and Application (Drug Discovery & Repurposing, Clinical Research Trial, Personalized Medicine, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025

 

出版社 出版年月電子版価格 ページ数
Allied Market Research
アライドマーケットリサーチ
2018年7月US$5,370
シングルユーザライセンス
231

サマリー

この調査レポートは医療向け人工知能(AI)市場を分析・予測したAllied Market Researchの市場調査報告書です。

Overview

The global artificial intelligence (AI) in medicine market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025. AI is an intelligent system that applies various human intelligence-based functions such as reasoning, learning, and problem-solving skills. AI technology uses software and different algorithms in the field of pharmaceuticals to support the decision-making processes for existing drugs and repurposing drugs to treat other conditions, along with accelerating the clinical trials process by finding the right patients from several data sources.

Shortage of skilled healthcare professionals and increase in the processing power of AI systems that is projected to help improve the efficiency of drug discovery and management of clinical trials majorly drive the growth of the global artificial intelligence in medicine market. Furthermore, the growth in importance of precision medicine and rise in funding of the R&D activities for the use of AI technology in the field of medicine are expected to fuel the market growth. However, limited acceptance from healthcare professionals and limitations of AI decision-making can impede the market growth. Untapped market opportunities available in developing regions such as India and China help to open new avenues for the growth of the artificial intelligence in medicine market in future.

The global artificial intelligence in medicine market is segmented based on product type, technology, application, and region. Based on product type, the market is segmented into hardware, software, and service. Based on technology, the market is classified into deep learning, querying method, natural language processing, and context aware processing. Based on application, the market is categorized into drug discovery & repurposing, clinical research trial, personalized medicine, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities.
Market estimations are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product type, technology, application, and region.
In-depth analysis based on region assists to understand the regional market to help in strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Product Type

Hardware
Software
Service

By Technology

Deep Learning
Querying Method
Natural Language Processing
Context Aware Processing

By Application

Drug Discovery & Repurposing (Preclinical Phase)
Clinical Research Trial
Personalized Medicine
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

KEY PLAYERS PROFILED

Welltok, Inc.
Intel Corporation
Nvidia Corporation
Google Inc.
IBM Corporation
Microsoft Corporation
General Vision, Inc.
Enlitic, Inc.
BioXcel Corporation
Berg Health.

The other players of the artificial intelligence in medicine market include (companies not profiled in the report):

InSilico Medicine, Inc.
Globavir Biosciences, Inc.
GNS Healthcare
Flatiron Health
Benevolent AI
Atomwise
Verge Genomics
Cloud Pharmaceuticals
Recursion Pharmaceuticals



目次

Table of Contents

Chapter: 1: INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY MARKET SEGMENTS
1.3. KEY BENEFITS
1.4. RESEARCH METHODOLOGY
1.4.1. PRIMARY RESEARCH
1.4.2. SECONDARY RESEARCH
1.4.3. ANALYST TOOLS AND MODELS


Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3: MARKET LANDSCAPE

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. TOP INVESTMENT POCKETS
3.2.2. TOP WINNING STRATEGIES
3.3. PORTER'S FIVE FORCES ANALYSIS
3.3.1. BARGAINING POWER OF SUPPLIERS
3.3.2. THREAT OF NEW ENTRANTS
3.3.3. THREAT OF SUBSTITUTES
3.3.4. COMPETITIVE RIVALRY
3.3.5. BARGAINING POWER AMONG BUYERS
3.4. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING
3.5. MARKET DYNAMICS
3.5.1. DRIVERS
3.5.2. RESTRAINTS
3.5.3. OPPORTUNITIES

Chapter: 4: 3D NAND MARKET MARKET BY TYPE

4.1. OVERVIEW
4.2. SINGLE LEVEL CELL (SLC)
4.2.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
4.2.2. MARKET SIZE AND FORECAST BY REGION
4.2.3. MARKET ANALYSIS BY COUNTRY
4.3. MULTI LEVEL CELL MLC
4.3.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
4.3.2. MARKET SIZE AND FORECAST BY REGION
4.3.3. MARKET ANALYSIS BY COUNTRY
4.4. TRIPLE LEVEL CELL TLC
4.4.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
4.4.2. MARKET SIZE AND FORECAST BY REGION
4.4.3. MARKET ANALYSIS BY COUNTRY

Chapter: 5: 3D NAND MARKET MARKET BY APPLICATION

5.1. OVERVIEW
5.2. CAMERAS
5.2.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.2.2. MARKET SIZE AND FORECAST BY REGION
5.2.3. MARKET ANALYSIS BY COUNTRY
5.3. LAPTOPS PCS
5.3.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.3.2. MARKET SIZE AND FORECAST BY REGION
5.3.3. MARKET ANALYSIS BY COUNTRY
5.4. SMARTPHONE TABLETS
5.4.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.4.2. MARKET SIZE AND FORECAST BY REGION
5.4.3. MARKET ANALYSIS BY COUNTRY
5.5. OTHERS
5.5.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.5.2. MARKET SIZE AND FORECAST BY REGION
5.5.3. MARKET ANALYSIS BY COUNTRY

Chapter: 6: 3D NAND MARKET MARKET BY END USER

6.1. OVERVIEW
6.2. AUTOMOTIVE
6.2.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.2.2. MARKET SIZE AND FORECAST BY REGION
6.2.3. MARKET ANALYSIS BY COUNTRY
6.3. CONSUMER ELECTRONICS
6.3.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.3.2. MARKET SIZE AND FORECAST BY REGION
6.3.3. MARKET ANALYSIS BY COUNTRY
6.4. ENTERPRISE
6.4.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.4.2. MARKET SIZE AND FORECAST BY REGION
6.4.3. MARKET ANALYSIS BY COUNTRY
6.5. HEALTHCARE
6.5.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.5.2. MARKET SIZE AND FORECAST BY REGION
6.5.3. MARKET ANALYSIS BY COUNTRY
6.6. OTHERS
6.6.1. KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.6.2. MARKET SIZE AND FORECAST BY REGION
6.6.3. MARKET ANALYSIS BY COUNTRY

Chapter: 7: 3D NAND MARKET MARKET BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. KEY MARKET TRENDS AND OPPORTUNITIES
7.2.2. MARKET SIZE AND FORECAST BY TYPE
7.2.3. MARKET SIZE AND FORECAST BY APPLICATION
7.2.4. MARKET SIZE AND FORECAST BY END USER
7.2.5. MARKET SIZE AND FORECAST BY COUNTRY
7.2.6. US 3D NAND MARKET MARKET
7.2.6.1. MARKET SIZE AND FORECAST BY TYPE
7.2.6.2. MARKET SIZE AND FORECAST BY APPLICATION
7.2.6.3. MARKET SIZE AND FORECAST BY END USER
7.2.7. CANADA 3D NAND MARKET MARKET
7.2.7.1. MARKET SIZE AND FORECAST BY TYPE
7.2.7.2. MARKET SIZE AND FORECAST BY APPLICATION
7.2.7.3. MARKET SIZE AND FORECAST BY END USER
7.2.8. MEXICO 3D NAND MARKET MARKET
7.2.8.1. MARKET SIZE AND FORECAST BY TYPE
7.2.8.2. MARKET SIZE AND FORECAST BY APPLICATION
7.2.8.3. MARKET SIZE AND FORECAST BY END USER
7.3. EUROPE
7.3.1. KEY MARKET TRENDS AND OPPORTUNITIES
7.3.2. MARKET SIZE AND FORECAST BY TYPE
7.3.3. MARKET SIZE AND FORECAST BY APPLICATION
7.3.4. MARKET SIZE AND FORECAST BY END USER
7.3.5. MARKET SIZE AND FORECAST BY COUNTRY
7.3.6. UK 3D NAND MARKET MARKET
7.3.6.1. MARKET SIZE AND FORECAST BY TYPE
7.3.6.2. MARKET SIZE AND FORECAST BY APPLICATION
7.3.6.3. MARKET SIZE AND FORECAST BY END USER
7.3.7. GERMANY 3D NAND MARKET MARKET
7.3.7.1. MARKET SIZE AND FORECAST BY TYPE
7.3.7.2. MARKET SIZE AND FORECAST BY APPLICATION
7.3.7.3. MARKET SIZE AND FORECAST BY END USER
7.3.8. FRANCE 3D NAND MARKET MARKET
7.3.8.1. MARKET SIZE AND FORECAST BY TYPE
7.3.8.2. MARKET SIZE AND FORECAST BY APPLICATION
7.3.8.3. MARKET SIZE AND FORECAST BY END USER
7.3.9. REST OF EUROPE 3D NAND MARKET MARKET
7.3.9.1. MARKET SIZE AND FORECAST BY TYPE
7.3.9.2. MARKET SIZE AND FORECAST BY APPLICATION
7.3.9.3. MARKET SIZE AND FORECAST BY END USER
7.4. ASIA PACIFIC
7.4.1. KEY MARKET TRENDS AND OPPORTUNITIES
7.4.2. MARKET SIZE AND FORECAST BY TYPE
7.4.3. MARKET SIZE AND FORECAST BY APPLICATION
7.4.4. MARKET SIZE AND FORECAST BY END USER
7.4.5. MARKET SIZE AND FORECAST BY COUNTRY
7.4.6. CHINA 3D NAND MARKET MARKET
7.4.6.1. MARKET SIZE AND FORECAST BY TYPE
7.4.6.2. MARKET SIZE AND FORECAST BY APPLICATION
7.4.6.3. MARKET SIZE AND FORECAST BY END USER
7.4.7. JAPAN 3D NAND MARKET MARKET
7.4.7.1. MARKET SIZE AND FORECAST BY TYPE
7.4.7.2. MARKET SIZE AND FORECAST BY APPLICATION
7.4.7.3. MARKET SIZE AND FORECAST BY END USER
7.4.8. INDIA 3D NAND MARKET MARKET
7.4.8.1. MARKET SIZE AND FORECAST BY TYPE
7.4.8.2. MARKET SIZE AND FORECAST BY APPLICATION
7.4.8.3. MARKET SIZE AND FORECAST BY END USER
7.4.9. SOUTH KOREA 3D NAND MARKET MARKET
7.4.9.1. MARKET SIZE AND FORECAST BY TYPE
7.4.9.2. MARKET SIZE AND FORECAST BY APPLICATION
7.4.9.3. MARKET SIZE AND FORECAST BY END USER
7.4.10. REST OF ASIA PACIFIC 3D NAND MARKET MARKET
7.4.10.1. MARKET SIZE AND FORECAST BY TYPE
7.4.10.2. MARKET SIZE AND FORECAST BY APPLICATION
7.4.10.3. MARKET SIZE AND FORECAST BY END USER
7.5. LAMEA
7.5.1. KEY MARKET TRENDS AND OPPORTUNITIES
7.5.2. MARKET SIZE AND FORECAST BY TYPE
7.5.3. MARKET SIZE AND FORECAST BY APPLICATION
7.5.4. MARKET SIZE AND FORECAST BY END USER
7.5.5. MARKET SIZE AND FORECAST BY COUNTRY
7.5.6. LATIN AMERICA 3D NAND MARKET MARKET
7.5.6.1. MARKET SIZE AND FORECAST BY TYPE
7.5.6.2. MARKET SIZE AND FORECAST BY APPLICATION
7.5.6.3. MARKET SIZE AND FORECAST BY END USER
7.5.7. MIDDLE EAST 3D NAND MARKET MARKET
7.5.7.1. MARKET SIZE AND FORECAST BY TYPE
7.5.7.2. MARKET SIZE AND FORECAST BY APPLICATION
7.5.7.3. MARKET SIZE AND FORECAST BY END USER
7.5.8. AFRICA 3D NAND MARKET MARKET
7.5.8.1. MARKET SIZE AND FORECAST BY TYPE
7.5.8.2. MARKET SIZE AND FORECAST BY APPLICATION
7.5.8.3. MARKET SIZE AND FORECAST BY END USER

Chapter: 8: COMPANY PROFILES

8.1. SAMSUNG ELECTRONICS CO LTD
8.1.1. COMPANY OVERVIEW
8.1.2. BUSINESS PERFORMANCE
8.1.3. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.2. TOSHIBA CORPORATION
8.2.1. COMPANY OVERVIEW
8.2.2. BUSINESS PERFORMANCE
8.2.3. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.3. SK HYNIX SEMICONDUCTOR INC
8.3.1. COMPANY OVERVIEW
8.3.2. BUSINESS PERFORMANCE
8.3.3. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.4. MICRON TECHNOLOGY INC
8.4.1. COMPANY OVERVIEW
8.4.2. BUSINESS PERFORMANCE
8.4.3. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.5. INTEL CORPORATION
8.5.1. COMPANY OVERVIEW
8.5.2. BUSINESS PERFORMANCE
8.5.3. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.6. APPLE INC
8.6.1. COMPANY OVERVIEW
8.6.2. BUSINESS PERFORMANCE
8.6.3. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.7. LENOVO GROUP LTD
8.7.1. COMPANY OVERVIEW
8.7.2. BUSINESS PERFORMANCE
8.7.3. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.8. ADVANCED MICRO DEVICES
8.8.1. COMPANY OVERVIEW
8.8.2. BUSINESS PERFORMANCE
8.8.3. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.9. STMICROELECTRONICS
8.9.1. COMPANY OVERVIEW
8.9.2. BUSINESS PERFORMANCE
8.9.3. KEY STRATEGIC MOVES AND DEVELOPMENTS
8.10. SANDISK CORPORATION
8.10.1. COMPANY OVERVIEW
8.10.2. BUSINESS PERFORMANCE
8.10.3. KEY STRATEGIC MOVES AND DEVELOPMENTS

List of Tables

NA

List of Figures

FIGURE 01. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 20152018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 20152018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 20152018*
FIGURE 06. LOW BARGAINING POWER OF BUYERS
FIGURE 07. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08. HIGH THREAT OF NEW ENTRANTS
FIGURE 09. LOW THREAT OF SUBSTITUTION
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE HARDWARE IN MEDICINE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE SOFTWARE IN MEDICINE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE SERVICES IN MEDICINE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR DEEP LEARNING, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR QUERYING METHOD, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FOR CONTEXT AWARE PROCESSING, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR CLINICAL RESEARCH TRIAL, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET FOR OTHER MEDICINE APPLICATIONS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22. ALPHABET INC.: REVENUE, 20152017 ($MILLION)
FIGURE 23. ALPHABET INC.: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 24. ALPHABET INC.: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 25. IBM: REVENUE, 20152017 ($MILLION)
FIGURE 26. IBM: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 27. IBM: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 28. INTEL CORPORATION: REVENUE, 20152017 ($MILLION)
FIGURE 29. INTEL CORPORATION: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 30. INTEL CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 31. MICROSOFT CORPORATION: REVENUE, 20152017 ($MILLION)
FIGURE 32. MICROSOFT CORPORATION: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33. MICROSOFT CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 34. NVIDIA: REVENUE, 20162018 ($MILLION)
FIGURE 35. NVIDIA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36. NVIDIA: REVENUE SHARE BY GEOGRAPHY, 2018 (%)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る